the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Obsessive-Compulsive Disorder: Strategies to Maximize Opportunities in a Small Market

Published by Decision Resources, Inc. Contact us : +1-860-674-8796
Published 2008/05 Content info 24 Pages
Product code DR66538
Price From  US $ 1669 Order/Price list
US $ 1669 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Introduction

Although the obsessive-compulsive disorder (OCD) market is small and OCD diagnosis rates are low, this market is characterized by substantial unmet need and commercial opportunity. Companies looking to expand their agents into this market need to explore unconventional strategies that will minimize the resources necessary to ensure success in OCD.

Get the Answers You Need to Shape Your Strategy

  • Despite the high use of drug therapy in the treatment of OCD, 40-60% of patients do not achieve suffi cient relief from their symptoms. What opportunities does this unmet need present to developers? Are any agents now in development likely to meet this need?
  • Due to the large percentage of patients who are not suffi ciently treated with available approved agents, psychiatrists often prescribe off-label agents to treat OCD. How well do these off-label agents perform in the OCD market? Will pending guidance from the FDA regarding the distribution of data from clinical trials in off-label indications help companies increase their market share for off-label treatments?
  • Although there are few agents in commercial development for OCD, there are agents being investigated for their effi cacy in OCD by research and medical organizations. What does the possible infl ux of a large number of new agents to treat OCD mean for currently available treatments? How can emerging agents differentiate themselves from other current and emerging agents?

Scope

  • Overview of OCD: symptoms and diagnosis, etiology.
  • Epidemiology: Decision Resources estimates of the number of prevalent cases of OCD in the major markets over 2007-2017 and the number of diagnosed and drug-treated cases in the major markets in 2007.
  • Treatment algorithms: a treatment decision tree, a listing of currently used agents, and profi les of leading agents.
  • Use of off-label agents: discussion of agents commonly used off-label, physician attitudes toward off-label use, pending FDA proposals to broaden marketing of these agents.
  • OCD market: 2007 sales fi gures, current market dynamics, strategies for maximizing market potential.
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.